CRISPR-Cas9–based target validation for p53-reactivating model compounds
November 23rd, 2015 by Michael Wanzel
Nature Chemical Biology 12, 22 (2016). doi:10.1038/nchembio.1965
Authors: Michael Wanzel, Jonas B Vischedyk, Miriam P Gittler, Niklas Gremke, Julia R Seiz, Mirjam Hefter, Magdalena Noack, Rajkumar Savai, Marco Mernberger, Joël P Charles, Jean Schneikert, Anne Catherine Bretz, Andrea Nist & Thorsten Stiewe